These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 25845966)
1. High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver Disease. Reddy KR; O'Leary JG; Kamath PS; Fallon MB; Biggins SW; Wong F; Patton HM; Garcia-Tsao G; Subramanian RM; Thacker LR; Bajaj JS; Liver Transpl; 2015 Jul; 21(7):881-8. PubMed ID: 25845966 [TBL] [Abstract][Full Text] [Related]
2. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score. Kwong AJ; Lai JC; Dodge JL; Roberts JP Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624 [TBL] [Abstract][Full Text] [Related]
3. Outcomes After Listing for Liver Transplant in Patients With Acute-on-Chronic Liver Failure: The Multicenter North American Consortium for the Study of End-Stage Liver Disease Experience. O'Leary JG; Bajaj JS; Tandon P; Biggins SW; Wong F; Kamath PS; Garcia-Tsao G; Maliakkal B; Lai J; Fallon M; Vargas HE; Thuluvath P; Subramanian R; Thacker LR; Reddy KR Liver Transpl; 2019 Apr; 25(4):571-579. PubMed ID: 30724010 [TBL] [Abstract][Full Text] [Related]
4. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U; J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408 [TBL] [Abstract][Full Text] [Related]
5. Sex-based disparities in delisting for being "too sick" for liver transplantation. Cullaro G; Sarkar M; Lai JC Am J Transplant; 2018 May; 18(5):1214-1219. PubMed ID: 29194969 [TBL] [Abstract][Full Text] [Related]
6. Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation. Lai JC; Covinsky KE; Hayssen H; Lizaola B; Dodge JL; Roberts JP; Terrault NA; Feng S Liver Int; 2015 Sep; 35(9):2167-73. PubMed ID: 25644788 [TBL] [Abstract][Full Text] [Related]
7. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM; Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643 [TBL] [Abstract][Full Text] [Related]
8. Do Social Determinants Define "Too Sick" to Transplant in Patients With End-stage Liver Disease? Bababekov YJ; Hung YC; Chang DC; Rickert CG; Adler JT; Bethea E; Pomfret EA; Pomposelli JJ; Yeh H Transplantation; 2020 Feb; 104(2):280-284. PubMed ID: 31335769 [TBL] [Abstract][Full Text] [Related]
9. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List. Hsu EK; Shaffer ML; Gao L; Sonnenday C; Volk ML; Bucuvalas J; Lai JC Gastroenterology; 2017 Oct; 153(4):988-995. PubMed ID: 28711630 [TBL] [Abstract][Full Text] [Related]
10. A notable proportion of liver transplant candidates with alcohol-related cirrhosis can be delisted because of clinical improvement. Pose E; Torrents A; Reverter E; Perez-Campuzano V; Campos-Varela I; Avitabile E; Gratacós-Ginès J; Castellote J; Castells L; Colmenero J; Tort J; Ginès P; Crespo G J Hepatol; 2021 Aug; 75(2):275-283. PubMed ID: 33746085 [TBL] [Abstract][Full Text] [Related]
11. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality. Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024 [TBL] [Abstract][Full Text] [Related]
13. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk. Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185 [TBL] [Abstract][Full Text] [Related]
14. Disability in patients with end-stage liver disease: Results from the functional assessment in liver transplantation study. Samoylova ML; Covinsky KE; Haftek M; Kuo S; Roberts JP; Lai JC Liver Transpl; 2017 Mar; 23(3):292-298. PubMed ID: 27884053 [TBL] [Abstract][Full Text] [Related]
15. The impact of infections on delisting patients from the liver transplantation waiting list. Alferink LJM; Oey RC; Hansen BE; Polak WG; van Buuren HR; de Man RA; Schurink CAM; Metselaar HJ Transpl Int; 2017 Aug; 30(8):807-816. PubMed ID: 28403563 [TBL] [Abstract][Full Text] [Related]
16. Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study. Lai JC; Dodge JL; Sen S; Covinsky K; Feng S Hepatology; 2016 Feb; 63(2):574-80. PubMed ID: 26517301 [TBL] [Abstract][Full Text] [Related]
17. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation. Wong RJ; Gish RG; Ahmed A Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379 [TBL] [Abstract][Full Text] [Related]
18. Functional impairment in older liver transplantation candidates: From the functional assessment in liver transplantation study. Wang CW; Covinsky KE; Feng S; Hayssen H; Segev DL; Lai JC Liver Transpl; 2015 Dec; 21(12):1465-70. PubMed ID: 26359787 [TBL] [Abstract][Full Text] [Related]